Sure, this is more a case of the stock share price bearing a relationship with the way the net tangible assets are being managed and eventually devalued, there are doubts on whether Dr Campbell can actually do his job: develop the assets.
Ann: Positive preclinical data for deoxymabs in vasculitis, page-47
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $4.351K | 621.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2130203 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 4749803 | 5 |
View Market Depth
| Last trade - 11.02am 09/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |